Sci-Tech Seattle: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Seattle.

Press releases published on October 23, 2026

Oct. 23, 2026

Eikon Therapeutics Presents Data from PARP1-Selective and WRN Helicase Programs at the European Society for Medical Oncology Congress

Indeterminate GlobeNewswire

Oct. 23, 2026

Pasithea Therapeutics Announces Positive PAS-004 Clinical Data from Phase 1 Advanced Cancer Study Presented at ESMO Congress 2026

Indeterminate GlobeNewswire

Oct. 23, 2026

Precede Biosciences Presents ESMO 2026 Data Revealing Biology Associated with Response and Resistance to PSMA-Directed Radioligand Therapy in Advanced Prostate Cancer

Indeterminate GlobeNewswire

Oct. 23, 2026

KANZHUN LIMITED Announces Board Change

Indeterminate GlobeNewswire

Oct. 23, 2026

Bolt Biotherapeutics Announces Acquisition of Prana Therapies and $120 Million Concurrent Private Placement to Advance PRA-216 in Multiple High-Value Inflammatory Indications

Indeterminate GlobeNewswire

Oct. 23, 2026

PRF Technologies Issues Letter to Shareholders Highlighting $11.0 Million Cash Position, Entering Phase 2 Trial of OcuRing™-K and GridFeed™ Opportunity in AI Data Center Power

Indeterminate GlobeNewswire

Oct. 23, 2026

Arctic Wolf Named Best Security Vendor in CRN’s Annual Best of the Channel Awards

Indeterminate GlobeNewswire

Oct. 23, 2026

Elicio Therapeutics Presents Late-Breaking Phase 2 AMPLIFY-7P Results at ESMO Congress 2026 and Announces Simultaneous Publication in Nature Medicine

Indeterminate GlobeNewswire

Oct. 23, 2026

Micware Co., Ltd. to Report First Half of Fiscal Year 2027 Financial Results

Indeterminate GlobeNewswire

Oct. 23, 2026

Onconetix Provides Additional Strategic Bridge Financing to Realbotix LLC in Continued Support of Pending Acquisition

Indeterminate GlobeNewswire

Oct. 23, 2026

Lexicon Pharmaceuticals Provides Update on Baseline Patient Characteristics for Pivotal Phase 3 SONATA-HCM Study of Sotagliflozin in Symptomatic Hypertrophic Cardiomyopathy

Indeterminate GlobeNewswire

Oct. 23, 2026

Travel eSIM app Saily unveils coverage maps and data usage breakdown

Indeterminate GlobeNewswire

Oct. 23, 2026

ImPact Biotech Reports Encouraging Early Clinical Results From Phase 1 Study of Padeliporfin VTP in Pancreatic Cancer, with Seven Previously Unresectable Patients Undergoing Surgical Resection Following Treatment

Indeterminate GlobeNewswire

Oct. 23, 2026

Humacyte at ASN Kidney Week: Phase 3 Trial Built for Women Shows ATEV Advantage Over Fistula, Getting Patients Off Catheters Months Sooner

Indeterminate GlobeNewswire

Oct. 23, 2026

Dayforce to Acquire Ribbon AI Inc. to Advance Agentic Recruiting

Indeterminate GlobeNewswire

Oct. 23, 2026

Solo.io Introduces agentshield to Protect Organizations’ Existing Infrastructure From the AI Agents They Don’t Control

Indeterminate GlobeNewswire

Oct. 23, 2026

Glacier Fresh Breaks Through the Limitations of Traditional RO Systems: TankInside, Electric-Free, Easy to Install!

Indeterminate GlobeNewswire

Oct. 23, 2026

Immutep Announces Presentation of Quality of Life Data from EFTISARC-NEO Phase II Trial at ESMO 2026

Indeterminate GlobeNewswire

Oct. 23, 2026

CLICK HOLDINGS LIMITED CEO JEFFREY CHAN ISSUES LETTER TO SHAREHOLDERS HIGHLIGHTING 61.9% REVENUE GROWTH, SWING TO OPERATING PROFIT AND RECORD NET INCOME OF HK$14.6 MILLION

Indeterminate GlobeNewswire

Oct. 23, 2026

3 E Network Announces Entry into Material Definitive Agreement, Related Party Transaction and Unregistered Sale of Equity Securities

Indeterminate GlobeNewswire